Virological, immune and host genetics markers in the control of HIV infection

被引:0
作者
Mothe, Beatriz [1 ,2 ]
Ibarrondo, Javier [1 ,2 ]
Llano, Anuska [1 ,2 ]
Brander, Christian [1 ,2 ,3 ]
机构
[1] Hosp Badalona Germans Trias & Pujol, IrsiCaixa AIDS Res Inst HIVACAT, Badalona 08916, Spain
[2] Univ Autonoma Barcelona, Barcelona, Spain
[3] ICREA, Barcelona, Spain
关键词
HIV-1; long-term non-progressors (LTNP); Elite Controllers (EC); Highly exposed persistently seronegatives (HEPS); CCR5; CTL; Innate immunity; HIV control; immune correlates; HLA allele frequency; HUMAN-IMMUNODEFICIENCY-VIRUS; CYTOTOXIC-T-LYMPHOCYTE; LONG-TERM SURVIVORS; CLASS-I MOLECULES; CELL RESPONSES; DISEASE PROGRESSION; HLA-B; PROMOTER POLYMORPHISM; VIRAL LOAD; CHEMOKINE RECEPTORS;
D O I
10.1155/2009/360362
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
HIV infection, if left untreated, leads in most cases to the development of wide immune deterioration, opportunistic infections and eventually AIDS and death. The identification of individuals who despite persisting infection show no or few signs of HIV disease progression has spurred hopes that an effective HIV vaccine could be attainable. The design of such a vaccine will greatly depend on the precise definition of disease markers, host genetic and immune characteristics that mediate relative in vivo control of this virus. Accordingly, a number of viral factors and host genetic characteristics have been shown to play a crucial role in the control of HIV disease by delaying progression to AIDS or even preventing infection. There is also an improved understanding of humoral and cellular immune responses in terms of specificity, functional repertoire, longevity and tissue distribution and their ability to contain HIV replication. However, the definition of good immune correlates unequivocally and causally associated with protection or disease progression remains elusive. Here we review work on viral factors, host genetic markers and immunological determinants that have been identified in individuals with superior control of HIV infection or in subjects who remain uninfected despite frequent exposure to the viral pathogen.
引用
收藏
页码:105 / 120
页数:16
相关论文
共 148 条
[81]   Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cells [J].
Lichterfeld, M ;
Kaufmann, DE ;
Yu, XG ;
Mui, SK ;
Addo, MM ;
Johnston, MN ;
Cohen, D ;
Robbins, GK ;
Pae, E ;
Alter, G ;
Wurcel, A ;
Stone, D ;
Rosenberg, ES ;
Walker, BD ;
Altfeld, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 200 (06) :701-712
[82]   Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression [J].
Liu, HL ;
Chao, D ;
Nakayama, EE ;
Taguchi, H ;
Goto, M ;
Xin, XM ;
Takamatsu, J ;
Saito, H ;
Ishikawa, Y ;
Akaza, T ;
Juji, T ;
Takebe, Y ;
Ohishi, T ;
Fukutake, K ;
Maruyama, Y ;
Yashiki, SJ ;
Sonoda, S ;
Nakamura, T ;
Nagai, Y ;
Iwamoto, A ;
Shioda, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (08) :4581-4585
[83]   Analysis of genetic polymorphisms in CCR5, CCR2, stromal cell-derived factor-1, RANTES, and dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin in seronegative individuals repeatedly exposed to HIV-1 [J].
Liu, HL ;
Hwangbo, Y ;
Holte, S ;
Lee, J ;
Wang, CH ;
Kaupp, N ;
Zhu, HY ;
Celum, C ;
Corey, L ;
McElrath, MJ ;
Zhu, TF .
JOURNAL OF INFECTIOUS DISEASES, 2004, 190 (06) :1055-1058
[84]   Frequency of CCR5 genotypes in HIV-infected patients in Roraima, Brazil [J].
Guerra Corado, Andre de Lima ;
Villarouco da Silva, George Allan ;
Carvalho Leao, Renato Augusto ;
Granja, Fabiana ;
Naveca, Felipe Gomes .
BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2016, 20 (03) :314-315
[85]   Chemokines as regulators of T cell differentiation [J].
Luther, SA ;
Cyster, JG .
NATURE IMMUNOLOGY, 2001, 2 (02) :102-107
[86]   Influence of HLA supertypes on susceptibility and resistance to human immunodeficiency virus type 1 infection [J].
MacDonald, KS ;
Fowke, KR ;
Kimani, J ;
Dunand, VA ;
Nagelkerke, NJD ;
Ball, TB ;
Oyugi, J ;
Njagi, E ;
Gaur, LK ;
Brunham, RC ;
Wade, J ;
Luscher, MA ;
Krausa, P ;
Rowland-Jones, S ;
Ngugi, E ;
Bwayo, JJ ;
Plummer, FA .
JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (05) :1581-1589
[87]   Role for HLA class II molecules in HIV-1 suppression and cellular immunity following antiretroviral treatment [J].
Malhotra, U ;
Holte, S ;
Dutta, S ;
Berrey, MM ;
Delpit, E ;
Koelle, DM ;
Sette, A ;
Corey, L ;
McElrath, MJ .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (04) :505-517
[88]   Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1 [J].
Martin, Maureen P. ;
Qi, Ying ;
Gao, Xiaojiang ;
Yamada, Eriko ;
Martin, Jeffrey N. ;
Pereyra, Florencia ;
Colombo, Sara ;
Brown, Elizabeth E. ;
Shupert, W. Lesley ;
Phair, John ;
Goedert, James J. ;
Buchbinder, Susan ;
Kirk, Gregory D. ;
Telenti, Amalio ;
Connors, Mark ;
O'Brien, Stephen J. ;
Walker, Bruce D. ;
Parham, Peter ;
Deeks, Steven G. ;
McVicar, Daniel W. ;
Carrington, Mary .
NATURE GENETICS, 2007, 39 (06) :733-740
[89]   Association of DC-SIGN promoter polymorphism with increased risk for parenteral, but not mucosal, acquisition of human immunodeficiency virus type 1 infection [J].
Martin, MP ;
Lederman, MM ;
Hutcheson, HB ;
Goedert, JJ ;
Nelson, GW ;
van Kooyk, Y ;
Detels, R ;
Buchbinder, S ;
Hoots, K ;
Vlahov, D ;
O'Brien, SJ ;
Carrington, M .
JOURNAL OF VIROLOGY, 2004, 78 (24) :14053-14056
[90]  
Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934